A detailed history of Amundi transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Amundi holds 58,310 shares of CRL stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,310
Previous 57,702 1.05%
Holding current value
$11.6 Million
Previous $15.6 Million 22.96%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $125,485 - $163,387
608 Added 1.05%
58,310 $12 Million
Q1 2024

May 15, 2024

SELL
$203.52 - $273.43 $2.62 Million - $3.52 Million
-12,888 Reduced 18.26%
57,702 $15.6 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $4.26 Million - $6.19 Million
25,896 Added 57.94%
70,590 $16.7 Million
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $4.38 Million - $4.91 Million
-22,543 Reduced 33.53%
44,694 $8.76 Million
Q2 2023

Aug 14, 2023

SELL
$183.71 - $210.25 $20.1 Million - $23 Million
-109,173 Reduced 61.89%
67,237 $14.1 Million
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $12.3 Million - $16.6 Million
63,983 Added 56.91%
176,410 $35.6 Million
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $5.08 Million - $6.44 Million
-25,753 Reduced 18.64%
112,427 $24.5 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $10.1 Million - $13.8 Million
-55,123 Reduced 28.52%
138,180 $29.8 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $10 Million - $14.8 Million
49,086 Added 34.04%
193,303 $40.7 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $1.26 Million - $1.78 Million
4,915 Added 3.53%
144,217 $43.6 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $18.1 Million - $23.1 Million
-51,448 Reduced 26.97%
139,302 $49 Million
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $13.1 Million - $16.1 Million
35,082 Added 22.54%
190,750 $78.7 Million
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $45.8 Million - $57.9 Million
155,668 New
155,668 $57.6 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.